Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Jakupciak

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Review of Molecular Diagnostics|September 10, 2005
Real-time telomerase activity measurements for detection of cancerJohn P Jakupciak
Journal of Biomarkers|August 29, 2015
Population-Sequencing as a Biomarker for Sample CharacterizationJohn P Jakupciak
Molecular Ecology Resources|May 14, 2011
Biological agent detection technologiesJohn P Jakupciak, Rita R Colwell
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 15, 2010
3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy coresBrian Reguly, John P Jakupciak, Ryan L Parr
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Standards for validation of cancer biomarkersCatherine D O'Connell, Donald H Atha, John P Jakupciak
Biomed Research International|March 14, 2013
Mitochondria and cancerRyan Parr, Andrew Harbottle, John P Jakupciak, et al.
Expert Review of Molecular Diagnostics|July 11, 2006
Advances in Huntington's disease diagnostics: development of a standard reference materialBarbara C Levin, Kristy L Richie, John P Jakupciak
Current Opinion in Molecular Therapeutics|January 25, 2007
Analysis of potential cancer biomarkers in mitochondrial DNAJohn P Jakupciak, Gabriel D Dakubo, Samantha Maragh, et al.
Cancer Cell International|March 17, 2007
Clinical implications and utility of field cancerizationGabriel D Dakubo, John P Jakupciak, Mark A Birch-Machin, et al.
Clinical Chemistry|June 14, 2005
Preparation and characterization of candidate reference materials for telomerase assaysJohn P Jakupciak, Peter E Barker, Wendy Wang, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Review of Molecular Diagnostics|September 10, 2005
Real-time telomerase activity measurements for detection of cancerJohn P Jakupciak
Journal of Biomarkers|August 29, 2015
Population-Sequencing as a Biomarker for Sample CharacterizationJohn P Jakupciak
Molecular Ecology Resources|May 14, 2011
Biological agent detection technologiesJohn P Jakupciak, Rita R Colwell
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 15, 2010
3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy coresBrian Reguly, John P Jakupciak, Ryan L Parr
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Standards for validation of cancer biomarkersCatherine D O'Connell, Donald H Atha, John P Jakupciak
Biomed Research International|March 14, 2013
Mitochondria and cancerRyan Parr, Andrew Harbottle, John P Jakupciak, et al.
Expert Review of Molecular Diagnostics|July 11, 2006
Advances in Huntington's disease diagnostics: development of a standard reference materialBarbara C Levin, Kristy L Richie, John P Jakupciak
Current Opinion in Molecular Therapeutics|January 25, 2007
Analysis of potential cancer biomarkers in mitochondrial DNAJohn P Jakupciak, Gabriel D Dakubo, Samantha Maragh, et al.
Cancer Cell International|March 17, 2007
Clinical implications and utility of field cancerizationGabriel D Dakubo, John P Jakupciak, Mark A Birch-Machin, et al.
Clinical Chemistry|June 14, 2005
Preparation and characterization of candidate reference materials for telomerase assaysJohn P Jakupciak, Peter E Barker, Wendy Wang, et al.
Pageof 3